Ossotide Drug Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global ossotide drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Ossotide is a bone-building chemical that has been used to stimulate the development of osteoblasts. Increased incidences of bone and joint injuries, particularly among the elderly, as well as an increase in the number of obese and overweight persons, are fueling the growth of the market.

Moreover, the rising prevalence of arthritis is also contributing significantly to the growth of the market. Arthritis has become more common in the US, and it will continue to rise during the forecast period. According to the article published by the CDC in February 2022, more than 22% of American adults (about 52.5 million persons) had doctor-diagnosed arthritis or rheumatic ailment. Doctor-diagnosed arthritis affects 7.3% of persons aged 18 to 44, 30.3% of those aged 45 to 64, and 49.7% of those aged 65 and above. Doctor-diagnosed arthritis affects 26% of women and 19.1% of men. Doctor-diagnosed arthritis affects 2.9 million Hispanic adults and 4.6 million non-Hispanic blacks. The organization predicts that the number of persons living with arthritis (adults of age 18 and above) will reach 67 million by 2030.

China also has a significant prevalence of arthritis. According to the article published by BioMed Central Ltd. in 2017, the incidence of rheumatoid arthritis in China ranges from 0.2% to 0.36%, which accounts for5 to 10 million people. Osteoarthritis, like rheumatoid arthritis, is a prevalent form of arthritis that results from articular degradation as people age. At the end of 2017, China’s population of adults aged 60 and more totaled 241 million, accounting for 17.3% of the total population. According to some studies, over 60% of Chinese individuals aged 60 and up suffer from osteoarthritis, which is increasing as the population ages.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Harbin Medisan Pharmaceutical Co Ltd, Heilongjiang ZBD Pharmaceutical Co Ltd, Nanjing Xinbai Pharmaceutical Co Ltd, DSM Jiangshan Pharmaceutical (Jiangsu) Co Ltd., and Jilin HuinanHuifa Pharmaceutical Co. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Ossotide Drug Market Report by Segment

By Type

• Ossotide Tablets
• Ossotide Injections

By Application

• Fractures
• Osteoarthritis
• Rheumatism
• Rheumatoid Arthritis